HopeStage
Back to all studies
Enrolling By InvitationNCT07488663

MODELING OCD AND EXPLORING TREATMENT RESPONSE USING INNOVATIVE THERAPIES AND STEM CELLS

Device studyAges 18–65Italy
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 65 years.

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: April 30, 2023
Recruitment status
Enrolling By Invitation
Enrollment listed in the registry
60
Sponsor
ASST Fatebenefratelli Sacco
Sponsor type
Unknown or unclear
Study type
Device
Intervention type
DEVICE
Study phase
Not clearly listed
Locations
Italy
Age range
From 18 Years to 65 Years
Official registry ID
NCT07488663
Official title
Show the full official title

FROM DISEASE MODELING TO THE MOLECULAR BASES OF TREATMENT RESPONSE FOR OBSESSIVE-COMPULSIVE DISORDER USING INNOVATIVE THERAPIES AND PATIENT-DERIVED PLURIPOTENT STEM CELLS

Get this study by email

HopeStage may email me about this study.
Loading the security check...

Recruitment & locations

By invitation

Milan

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is ASST Fatebenefratelli Sacco.

Who can participate?

Listed age limits: 18 years to 65 years.

Is this study still recruiting?

The registry lists this study as enrolling by invitation.

Want to explore more studies?

Explore studies